of gilts against gonadotropin-releasing hormone: effects on secretion of gonadotropins, reproductive function, and responses to agonists of gonadotropin-releasing hormone.
In order to reduce the impact of HBV infection, schedules for active immunization
, double doses of active immunization
and both active and passive immunization against this infection have been investigated.
Prevenar 13 is approved in the EU for active immunization
for the prevention of invasive disease, pneumonia and acute otitis media caused byvaccine-type S.
At least five such vaccines addressing composite targets in an active immunization
strategy are in early stages of the developmental pipeline.
BASEL -- US Food and Drug Administration (FDA) has approved the use of Menveo(r) (Meningococcal [Groups A, C, Y and W-135] Oligosaccharide Diphtheria CRM197 Conjugate Vaccine) for active immunization
to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135 in individuals 2 to 10 years of age1.
The vaccine is indicated for active immunization
to prevent invasive meningococcal disease caused by Neisseria meningitides serogroups A, C, Y, and W135.
Afluria is indicated for the active immunization
of people ages 18 and older against flu caused by influenza virus subtypes A and type B present in the vaccine.
Intellect has incorporated proprietary safety features into its ANTISENILIN monoclonal antibody and RECALL-VAXTM technology platforms for both passive and active immunization
, respectively, to minimize the potential for adverse side-effects by generating antibodies that bind only the toxic beta amyloid and not the Amyloid Precursor Protein.
The use of licensed vaccines for active immunization
of the immunocompromised host.
Prevenar 13 also is available through the World Health Organization (WHO) pre-qualification program for active immunization
of infants and young children, as well as adults 50 years and older.
The company said Quadracel is approved by the US Food and Drug Administration (FDA) for active immunization
against diphtheria, tetanus, pertussis and poliomyelitis in children four through six years of age.
The new vaccine is indicated for active immunization
to prevent invasive meningococcal disease caused by Neisseria meningitides serogroups A, C, Y, and W-135.